Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study.
about
The use and misuse of positron emission tomography in lung cancer evaluation18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancerSequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II studyThe role of octreotate scan in discrimination of solitary pulmonary nodule.18F-FDG PET/CT-based gross tumor volume definition for radiotherapy in head and neck cancer: a correlation study between suitable uptake value threshold and tumor parameters.The utility of 18 F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratificationThe promise and pitfalls of positron emission tomography and single-photon emission computed tomography molecular imaging-guided radiation therapy.Prospective use of serial questionnaires to evaluate the therapeutic efficacy of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in suspected lung cancer.Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer.Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer.Metabolic response assessment with (18)F-FDG PET/CT: inter-method comparison and prognostic significance for patients with non-small cell lung cancer.Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.A phase I trial of high-dose palliative radiotherapy plus concurrent weekly Vinorelbine and Cisplatin in patients with locally advanced and metastatic NSCLCOxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trialPositron emission tomography in esophageal cancer.The mediastinal staging accuracy of 18F-Fluorodeoxyglycose positron emission tomography/computed tomography in non-small cell lung cancer with variable time intervals to surgery.Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15-19, 2016; Tübingen, Germany.Factors Associated With the Use of Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer in Alberta, Canada: A Population-based Study.PET and PET-CT in radiation treatment planning for lung cancer.Recent advances in radiotherapy for thoracic tumours.Improved survival with dose-escalated radiotherapy in stage III non-small-cell lung cancer: analysis of the National Cancer Database.Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer.Staging of non-small cell lung cancer (NSCLC).Use of Positron Emission Tomography/Computed Tomography in Radiation Treatment Planning for Lung Cancer.Advances in radiological staging of non-small cell lung cancer (NSCLC).Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancer.Health technology assessment and cancer imaging: who should be setting the agenda?F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment.Imaging with F-18 FDG PET is superior to Tl-201 SPECT in the staging of non-small cell lung cancer for radical radiation therapy.Role of positron emission tomography in lung cancer.The impact of hybrid PET-CT scan on overall oncologic management, with a focus on radiotherapy planning: a prospective, blinded study.An iterative technique to segment PET lesions using a Monte Carlo based mathematical model.The role of integrated 18F-FDG PET-CT as a staging tool for limited-stage small cell lung cancer: a retrospective study.Follow up results of a prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer.
P2860
Q27021838-05BF3882-9C6C-4B7E-8D48-F22223391ED4Q28346531-992C560D-075A-4D9D-9C88-93BBBDBA96AAQ33289242-335C0753-8F35-42CF-AEC4-CDDE790663C5Q34111240-B19ADBC7-2A42-483B-A4E4-85739A925E74Q34142516-C71DE0F3-7CE8-4E86-9131-D7968E28F41DQ35093230-FC61B73A-380C-47E7-9DC1-72CF0D51143BQ35111985-94268AEE-AE43-4774-BCAC-F604767DA208Q35535445-BCB6B4B8-5248-4D97-AB9B-0C955B5D0A54Q35584486-40A42A6C-D8FC-4263-84A1-BED55FD9EA6AQ35783387-1A4CED06-F029-4DD6-9AF0-93F6036CC84BQ36024114-237BABD2-859C-4CB8-BC34-8792695173C0Q36225895-C3715B0A-089D-4BAA-ADB5-4B3108CC51A8Q36615344-6B68EB37-6FB7-4A8C-9F7A-AA42CE24CDEFQ36616213-7E9B4FCA-C7A3-4D91-AAA2-EDC9F89BD25DQ37072496-87FC613D-FA83-45F1-AD7A-B126A0F5120AQ37131297-369B62D6-5873-4F11-8496-FD277983083CQ37230617-BD02B69B-B874-463F-8FB3-4493465B03DCQ37433213-D45E7B15-E5E1-4DB5-AFE3-9D4B19831E74Q37732292-6B641041-1792-4698-9666-21C4E2BA6B8CQ38155854-DFD7C040-7727-42AF-A17F-2AF47094801EQ39510875-BBC41B46-7C3D-4298-A96B-A4AA0D4E78B0Q40065867-824BC352-EABA-482D-8B2D-26CF10FB37BBQ40895862-36FE354A-95CC-43E5-AF63-0DC27BFABE7CQ41677756-8D143F6A-8F31-48D6-A5F3-7EB54F28F0E2Q41973755-993AF46F-F960-4F89-AA58-5C6BC77C456AQ42232269-2E070EE4-BEF7-4044-A47D-F7D2A7D05F8CQ43183480-280205E4-028F-4F3B-AB9D-D85DBBE91F85Q43732874-F5E44472-8A7D-4F5D-97A2-F1DA2D358106Q43923140-1740F0E1-62CE-4F1F-A614-420C1559C2BBQ46186435-86B5015A-D550-4D48-92A7-C91942C70844Q46873535-54434D21-8AC1-4A57-B555-5AA5D7EE4179Q48402423-F14E2678-5E36-48D6-B689-C2C3B97BD44AQ53149549-24D1300C-66A1-41F9-AF16-BE6663F3E164Q55285220-15597CD3-C46C-4E85-A283-E87742D7A5C4
P2860
Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical impact of (18)F fluor ...... g cancer: a prospective study.
@ast
Clinical impact of (18)F fluor ...... g cancer: a prospective study.
@en
type
label
Clinical impact of (18)F fluor ...... g cancer: a prospective study.
@ast
Clinical impact of (18)F fluor ...... g cancer: a prospective study.
@en
prefLabel
Clinical impact of (18)F fluor ...... g cancer: a prospective study.
@ast
Clinical impact of (18)F fluor ...... g cancer: a prospective study.
@en
P2093
P1476
Clinical impact of (18)F fluor ...... g cancer: a prospective study.
@en
P2093
A F McKenzie
M P MacManus
P304
P356
10.1200/JCO.2001.19.1.111
P407
P577
2001-01-01T00:00:00Z